Pages that link to "Q24678763"
Jump to navigation
Jump to search
The following pages link to Outcome of AIDS-associated cryptococcal meningitis initially treated with 200 mg/day or 400 mg/day of fluconazole (Q24678763):
Displaying 27 items.
- Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal (Q27012487) (← links)
- A prospective longitudinal study of the clinical outcomes from cryptococcal meningitis following treatment induction with 800 mg oral fluconazole in Blantyre, Malawi (Q28534417) (← links)
- Treatment of cryptococcosis in the setting of HIV coinfection. (Q30366117) (← links)
- Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi (Q33588561) (← links)
- Cryptococcal meningitis: epidemiology and therapeutic options (Q33633343) (← links)
- Mortality among HIV-Infected Patients in Resource Limited Settings: A Case Controlled Analysis of Inpatients at a Community Care Center (Q33701907) (← links)
- Cryptococcal meningitis: A neglected NTD? (Q33852819) (← links)
- Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. (Q34020746) (← links)
- Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients (Q34247688) (← links)
- A repurposing approach identifies off-patent drugs with fungicidal cryptococcal activity, a common structural chemotype, and pharmacological properties relevant to the treatment of cryptococcosis (Q34513852) (← links)
- Dose response effect of high-dose fluconazole for HIV-associated cryptococcal meningitis in southwestern Uganda (Q34874626) (← links)
- MORTALITY AFTER CLINICAL MANAGEMENT OF AIDS-ASSOCIATED CRYPTOCOCCAL MENINGITIS IN KENYA. (Q35073767) (← links)
- The effect of therapeutic lumbar punctures on acute mortality from cryptococcal meningitis (Q35635476) (← links)
- Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial (Q36870447) (← links)
- Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy (Q36996124) (← links)
- Predictors of outcome in routine care for Cryptococcal meningitis in Western Kenya: lessons for HIV outpatient care in resource-limited settings (Q37043583) (← links)
- New Insights into HIV/AIDS-Associated Cryptococcosis (Q37156556) (← links)
- Cryptococcal meningoencephalitis in human immunodeficiency virus/acquired immunodeficiency syndrome in douala, cameroon: a cross sectional study (Q37201795) (← links)
- Minimizing fungal disease deaths will allow the UNAIDS target of reducing annual AIDS deaths below 500 000 by 2020 to be realized (Q37393668) (← links)
- Treatment of cryptococcal meningitis in resource limited settings (Q37545277) (← links)
- Pharmacotherapy of cryptococcosis (Q37587230) (← links)
- Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries (Q38111887) (← links)
- Nanoparticle-Based Mycosis Vaccine (Q40183778) (← links)
- High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial (Q43678311) (← links)
- Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis (Q46248271) (← links)
- Long-term follow-up and survival of antiretroviral-naive patients with cryptococcal meningitis in the pre-antiretroviral therapy era, Gauteng Province, South Africa. (Q53427967) (← links)
- Treatment for HIV-associated cryptococcal meningitis (Q57275580) (← links)